208 related articles for article (PubMed ID: 8657123)
41. p53 modulation of DNA topoisomerase IIalpha gene expression.
Joshi AA; Wang Q; Suttle DP
Cell Biochem Biophys; 2000; 33(2):209-16. PubMed ID: 11325041
[No Abstract] [Full Text] [Related]
42. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES
Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516
[TBL] [Abstract][Full Text] [Related]
43. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
[TBL] [Abstract][Full Text] [Related]
44. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
45. Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha.
Lee CG; Hague LK; Li H; Donnelly R
Cell Cycle; 2004 May; 3(5):638-47. PubMed ID: 15034300
[TBL] [Abstract][Full Text] [Related]
46. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
47. EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
Li Y; Shen X; Wang X; Li A; Wang P; Jiang P; Zhou J; Feng Q
Sci Rep; 2015 Jun; 5():11009. PubMed ID: 26046674
[TBL] [Abstract][Full Text] [Related]
48. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
49. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta.
Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES
Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262
[TBL] [Abstract][Full Text] [Related]
50. 3,3'-diindolylmethane is a novel topoisomerase IIalpha catalytic inhibitor that induces S-phase retardation and mitotic delay in human hepatoma HepG2 cells.
Gong Y; Firestone GL; Bjeldanes LF
Mol Pharmacol; 2006 Apr; 69(4):1320-7. PubMed ID: 16385077
[TBL] [Abstract][Full Text] [Related]
51. Decreased topoisomerase IIalpha expression confers increased resistance to ICRF-193 as well as VP-16 in mouse embryonic stem cells.
Kobayashi M; Adachi N; Aratani Y; Kikuchi A; Koyama H
Cancer Lett; 2001 May; 166(1):71-7. PubMed ID: 11295289
[TBL] [Abstract][Full Text] [Related]
52. RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression.
Ramamoorthy M; Tadokoro T; Rybanska I; Ghosh AK; Wersto R; May A; Kulikowicz T; Sykora P; Croteau DL; Bohr VA
Nucleic Acids Res; 2012 Feb; 40(4):1621-35. PubMed ID: 22013166
[TBL] [Abstract][Full Text] [Related]
53. A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34.
Mirski SE; Sparks KE; Yu Q; Lang AJ; Jain N; Campling BG; Cole SP
Int J Cancer; 2000 Feb; 85(4):534-9. PubMed ID: 10699927
[TBL] [Abstract][Full Text] [Related]
54. All-trans retinoic acid suppresses topoisomerase IIα through the proteasomal pathway.
Li X; Li Y; Shen X; Fu S; Han S; Feng Q
Anticancer Drugs; 2015 Aug; 26(7):737-46. PubMed ID: 25946380
[TBL] [Abstract][Full Text] [Related]
55. Gene regulation and priming by topoisomerase IIα in embryonic stem cells.
Thakurela S; Garding A; Jung J; Schübeler D; Burger L; Tiwari VK
Nat Commun; 2013; 4():2478. PubMed ID: 24072229
[TBL] [Abstract][Full Text] [Related]
56. Redox control of cell cycle-coupled topoisomerase II alpha gene expression.
Goswami PC; Higashikubo R; Spitz DR
Methods Enzymol; 2002; 353():448-59. PubMed ID: 12078518
[No Abstract] [Full Text] [Related]
57. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
[TBL] [Abstract][Full Text] [Related]
58. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
59. Chromosome breakage is regulated by the interaction of the BLM helicase and topoisomerase IIalpha.
Russell B; Bhattacharyya S; Keirsey J; Sandy A; Grierson P; Perchiniak E; Kavecansky J; Acharya S; Groden J
Cancer Res; 2011 Jan; 71(2):561-71. PubMed ID: 21224348
[TBL] [Abstract][Full Text] [Related]
60. Evidence for a critical role of DNA topoisomerase IIalpha in drug sensitivity revealed by inducible antisense RNA in a human leukaemia cell line.
Towatari M; Adachi K; Marunouchi T; Saito H
Br J Haematol; 1998 Jun; 101(3):548-51. PubMed ID: 9633900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
